Morphologic changes in the peritoneal membrane of patients with renal disease

Journal of the American Society of Nephrology

Volumn 13, Issue 2, 2002, Pages 470-479

  Williams, John D ^a   Craig, Kathrine J ^a   Topley, Nicholas ^a   Von Ruhland, Christopher ^a   Fallon, Maureen ^a   Newman, Geoffrey R ^a   Mackenzie, Ruth K ^a   Williams, Geraint T ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN;

ADULT; ARTICLE; FEMALE; FIBROSIS; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYALINE DEGENERATION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PERITONEUM; PRIORITY JOURNAL; THICKNESS; UREMIA; VASCULAR DISEASE;

EID: 0036158071     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. What really happens to people on long-term peritoneal dialysis?
2. Longitudinal changes in peritoneal kinetics: The effects of peritoneal dialysis and peritonitis
3. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients: The Canada-USA (CA-NUSA) Peritoneal Dialysis Study Group
4. Functional longevity of the human peritoneum: How long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study
5. Peritoneal sclerosis in chronic peritoneal dialysis patients: Analysis of clinical presentation, risk factors, and peritoneal transport kinetics
6. Conventional and newer PD solutions
7. Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration
8. Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure
9. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis
10. Ultrastructural studies on the peritoneum with special reference to chronic ambulatory peritoneal dialysis
11. Morphology of the peritoneum in CAPD
12. Peritoneal morphology on maintenance dialysis
13. Peritonitis during continuous ambulatory peritoneal dialysis
14. Ultrastructural morphology of the peritoneum: New findings and speculations on transfer of solutes and water during peritoneal dialysis
15. Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis
16. The morphology of the human peritoneum in CAPD patients
17. An autopsy study of the peritoneal cavity from patients on continuous ambulatory peritoneal dialysis
18. Pathophysiology of peritoneal membrane failure
19. Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis
20. Enhancement of the periodic acid-Schiff (PAS) and periodic acid-thiocarbohydrazide-silver proteinate (PA-TCH-SP) reaction in LR white sections
21. Peritoneal sclerosis: One or two nosological entities?
22. Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties
23. Plasma levels of IL-1β, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients
24. Peritoneal vascular changes in continuous ambulatory peritoneal dialysis (CAPD): An in vivo model for the study of diabetic microangiopathy
25. Reduplicated basal lamina of small venules and mesothelium of human parietal peritoneum: Ultrastructural changes of reduplicated peritoneal basement membrane
26. Categorization of ultrastructural changes in peritoneal mesothelium, stroma and blood vessels in uremia and CAPD patients
27. Human soluble IL-6 receptor: Its detection and enhanced release by HIV infection
28. Advanced glycation and lipidoxidation of the peritoneal membrane: Respective roles of serum and peritoneal fluid reactive carbonyl compounds
29. Immunohistochemical detection of advanced glycosylation end products in the peritoneum and its possible pathophysiological role in CAPD
30. New concepts in the molecular biology and ultrastructural pathology of the peritoneum: Their significance for peritoneal dialysis
31. Growth factors VEGF and TGF-β1 in peritoneal dialysis
32. Hyperglycemia and diabetic kidney disease: The case for transforming growth factor-β as a key mediator
33. In vitro production of interleukin-1 receptor antagonist in chronic renal failure: CAPD and HD
34. Diabetic microangiopathy in the small bowel
35. Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: Role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysis
36. Ultrastructure of basement membranes of peritoneal capillaries in a chronic peritoneal infusion model in the rat